https://www.reuters.com/business/healthcare-pharmaceuticals/eisai-files-approval-alzheimers-drug-japan-2023-01-16/
0
0
1/16/23 at 1:19am
Organization
Reuters
Authors
Japanese drugmaker Eisai Co Ltd <a href="https://www.reuters.com/companies/4523.T" target="_blank">(4523.T)</a> said on Monday it had submitted a marketing authorisation application in Japan for its Alzheimer's drug lecanemab, which was recently granted accel…
Create an account
or login to join the discussion